|
OALib Journal期刊
ISSN: 2333-9721
费用：99美元
|
|
|
|
糖尿病动物模型研究进展及在中药研究中的应用
, PP. 951-958
Keywords: 糖尿病动物模型,糖尿病并发症,中药
Abstract:
持续攀升和高发的糖尿病严重危害人们的健康,防治糖尿病药物研发是解决问题的途径之一。动物模型是药物研发的有力工具,本文比较和分析了3类糖尿病动物模型的复制原理、方法和特点及其在中医药研究中的应用。同时还分析了降糖中成药的市场、应用和临床治疗优势,既看到了降糖中药临床和基础研究的不足,也从临床应用角度重点剖析了目前降糖中成药的作用特点和可能的优势,为体现中药综合干预糖尿病优势和特色的新药研究以及中药大品种二次开发提供一定的参考。
| [1] | vogelhg,wolfganghd.drugdiscoveryandevaluation:pharmacologicalassays[m].berlin:springerberlinheidelberg,1997:698-699.
|
| [2] | el-missiryma,othmanai,amerma.l-arginineamelioratesoxidativestressinalloxan-inducedexperimentaldiabetesmellitus[j].jappltoxicol,2004,24:93-97.
|
| [3] | liyw,niuyf,huangnx,etal.hypoglycemiceffectofbaicalinonalloxan-induceddiabeticmice[j].jkunmingmeduniv(昆明医科大学学报),2009,30:5-8.
|
| [4] | gonghl,yinyy,liwp,etal.effectsofpolygona-polysaccharoseonbloodglucoselevelandantioxidantactivityindiabeticmiceinducedbyalloxan[j].actaunivmedanhui(安徽医科大学学报),2008,43:538-540.
|
| [5] | xumh,liwp,gonghl.effectsofpolygona-polysaccharoseonbloodglucoseandlipidlevelofdiabeticmiceinducedbyalloxan[j].anhuimedpharmj(安徽医药),2009,13:263-265.
|
| [6] | guoyr.pharmacodynamicstudyoffermentingginsengtreatmentondiabetesmiceinducedbyalloxan(发酵人参对四氧嘧啶诱导糖尿病小鼠的疗效学研究)[d].yanbian:yanbianuniversity,2013.
|
| [7] | yangmh,chaikf,yangsb.observationonthestabilityofbloodglucoselevelindiabeticratmodelsinducedbyalloxanmonohydrate[j].chinjcompmed(中国比较医学杂志),2006,8:48-484.
|
| [8] | motshakerim,ebrahimim,gohym,etal.effectsofbrownseaweed(sargassumpolycystum)extractsonkidney,liver,andpancreasoftype2diabeticratmodel[j].evidbasedcomplementalternmed,2014,2014:379407.
|
| [9] | lianghx,yuanhy,lihd,etal.observationofstabilityofasimpletype2diabeticratmodel:combinationofhigh-fatdiet-fedandlow-dosestreptozotocin-induceddiabeticrat[j].chinpharmacolbull(中国药理学通报),2008,24:551-555.
|
| [10] | yanag,gezy,liujx,etal.effectofjiangtangxiaozhicapsuleonmorphologicalchangesofisletandliverinratmodeloftype2diabeticmellitus[j].chinajchinmatermed(中国中药杂志),2008,33:1067-1071.
|
| [11] | jingl,gezy,guoyj,etal.studyofjiangtangxiaozhitabletsondecreasinglevelsofbloodglucoseandserumlipidinratswithtype2diabetesmellitus[j].chinjexptraditmedformula(中国实验方剂学杂志),2012,18:161-165.
|
| [12] | weijp.mechanismsresearchoftcmtangweikangtreatmentthediabeticnephropathy(中药糖微康治疗糖尿病肾病的机制研究)[d].beijing:beijinguniversityofchinesemedicine,2004.
|
| [13] | linl,niq.pharmacodynamicstudyoftcmtangweikangtreatingthediabeticnephropathy[j].chinjinformtraditchin(中国中医药信息杂志),2001,8:25-27.
|
| [14] | wangq,gongmx,zhaoh,etal.theeffectofxiaokegranulesonlipidprofileandglucoselevelsindiabeticnephropathyrats[j].chinjpathophysiol(中国病理生理杂志),2003,19:664-667.
|
| [15] | jixm,wangq,qif,etal.theeffectofxiaokegranulesonglucoselevels,urineproteinlevelandglomerularmorphologyindiabeticnephropathyrats[j].chinjintegrtraditwest(中国中西医结合杂志),2004,24:534-537.
|
| [16] | fengwy.mechanismsandpharmacodynamicstudyoftcmzhouluotongtreatmentthediabeticperipheralneuropathy(周络通对糖尿病周围神经病变的保护作用及其作用机制研究)[d].beijing:beijinguniversityofchinesemedicine,2003.
|
| [17] | fengwy,houjy,chenw,etal.effectsofzhouluotongonthefunctionofsciaticnerve,activityofaldosereductaseandabilityofaldosereductaseagainstfreeradicalsintheratswithdiabetes[j].jbeijingunivtraditchinmed(北京中医药大学学报),2004,27:45-48.
|
| [18] | fda.guidanceforindustrydiabetesmellitus:developingdrugsandtherapeuticbiologicsfortreatmentandprevention[eb/ol].2008[2014-09-05].http://www.fda.gov/downloads/drugs/guidances/ucm071624.pdf.
|
| [19] | thejacksonlaboratory.comparisonofwidelyusedjaxmicefortype2diabetesandobesity[eb/ol].[2014-09-05].http://jaxmice.jax.org/diabetes/comparison.html.
|
| [20] | wickerls,millerbj,cokerlz,etal.geneticcontrolofdiabetesandinsulitisinthenonobesediabetic(nod)mouse[j].jexpmed,1987,165:1639-1654.
|
| [21] | fanmy,lumzp,fuxw,etal.reversalofdiabetesinbbratsbytransplantationofencapsulatedpancreaticislets[j].diabetes,1990,39:519-522.
|
| [22] | dubucpu.thedevelopmentofobesity,hyperinsulinemia,andhyperglycemiainob/obmice[j].metabolism,1976,25:1567-1574.
|
| [23] | chenh,charlato,tartagliala,etal.evidencethatthediabetesgeneencodestheleptinreceptor:identificationofamutationintheleptinreceptorgeneindb/dbmice[j].cell,1996,84:491-495.
|
| [24] | kakuk,provincem,permuttma.geneticanalysisofobesityinduceddiabetesassociatedwithalimitedcapacitytosynthesizeinsulininc57bl/ksmice:evidenceforpolygeniccontrol[j].diabetologia,1989,32:636-643.
|
| [25] | kodamah,fujitam,yamaguchii.developmentofhyperglycaemiaandinsulinresistanceinconsciousgeneticallydiabetic(c57bl/ksjdb/db)mice[j].diabetologia,1994,37:739-744.
|
| [26] | zhangsy.effectsofphlorizinonvascularcomplicationsindiabetesdb/dbmice(根皮苷对db/db小鼠视网膜保护机制的研究)[d].jinan:shandonguniversity,2013.
|
| [27] | caix.quantitativeproteomicsstudyontheprotectivemechanismofphlorizinonaortaindb/dbmice(根皮苷对db/db小鼠糖尿病心肌病变保护机制的定量蛋白质组学研究)[d].jinan:shandonguniversity,2013.
|
| [28] | gaox.effectofteapolysaccharidesonbloodglucoseandpancreaticfunctionofdb/dbmice(茶多糖对db/db小鼠血糖及胰岛功能的影响)[d].shijiazhuang:hebeimedicialuniversity,2013.
|
| [29] | liuc,zhangm,humy,etal.increasedglucagon-likepeptide-1secretionmaybeinvolvedinantidiabeticeffectsofginsenosides[j].jendocrinol,2013,217:185-196.
|
| [30] | nihx,yunj,yangxh.thestudyofginsenosideonppargammaexpressionofmononuclearmacrophageintype2diabetes[j].molbiolrep,2010,37:2975-2979.
|
| [31] | wangy.attenuationofberberineonlipopolysaccharide-inducedinflammatoryandapoptosisresponsesinβ-cellsviatlr4-independentjnk/nf-κbpathway[j].pharmbiol,2014,52:523-538
|
| [32] | moghaddamhk,baluchnejadmojaradt,roghanim,etal.berberinechlorideimprovedsynapticplasticityinstzinduceddiabeticrats[j].metabbraindis,2013,28:421-428.
|
| [33] | hanfq.clinicalresearchofqihuangmingmucapsuleintreatingnon-proliferationperioddiabeticretinopathy[j].chinapractmed(实用医学杂志),2012,7:178-179.
|
| [34] | wul,yanf,suh,etal.clinicalstudyonqihuangmingmugranuleforthetreatmentofdiabeticretinopathy[j].jtraditchinophthalmol(中国中医眼科杂志),2009,19:74-78.
|
| [35] | zhaojh.clinicalstudyonqihuangmingmugranulecombinedwithfufangdanshengforthetreatmentofdiabeticretinopathy[j].shanxijtraditchinmed(陕西中医杂志),2012,32:1594-1595.
|
| [36] | heqq.clinicalresearchofqiminggranuleintreatingnon-proliferationperioddiabeticretinopathy[j].chinajchinmed(中医杂志),2013,28:243-244.
|
| [37] | wangyy,yanghj.cultivationstrategyandpathanalysisonbigbrandchinesemedicineforsmallandmedium-sizedenterprises[j].chinajchinmatermed(中国中药杂志),2014,39:755-758.
|
| [38] | jiawp.diabetes:achallengeforchinainthe21stcentury[j].lancetdiabetesendocrinol,2014,2:e6-7.
|
| [39] | chanjc,zhangy,ningg.diabetesinchina:asocietalsolutionforapersonalchallenge[j].lancetdiabetesendocrinol,2014,2:969-979.
|
| [40] | internationaldiabetesfederation.diabetes:factsandfigures[db/ol].2014[2015-03-19].http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures.
|
| [41] | saltielar,kahncr.insulinsignallingandtheregulationofglucoseandlipidmetabolism[j].nature,2001,414:799-806.
|
| [42] | freemanjs.theincreasingepidemiologyofdiabetesandreviewofcurrenttreatmentalgorithms[j].jamosteopathassoc,2010,110:es2-6.
|
| [43] | wilds,roglicg,greena,etal.globalprevalenceofdiabetes:estimatesfortheyear2000andprojectionsfor2030[j].diabetescare,2004,27:1047-1053.
|
| [44] | worldhealthorganization.thefactsandfigureondiabetics[db/ol].2014[2015-03-19].http://www.who.int/diabetes/action_online/basics/zh/index3.html.
|
| [45] | xuy,wangl,hej,etal.prevalenceandcontrolofdiabetesinchineseadults[j].jama,2013,310:948-959.
|
| [46] | calcuttna,cooperme,kernts,etal.therapiesforhyperglycaemia-induceddiabeticcomplications:fromanimalmodelstoclinicaltrials[j].natrevdrugdiscov,2009,8:417-429.
|
| [47] | zhangj,wujf,zhenghe.experimentalstudyondiabeticmodelofratsinducedbystreptozotocin[j].jhebeinorthuniv(河北北方学院学报),2006,4:6-8.
|
| [48] | gaohl,liufy,xiazl.theoreticalstudyandapplicationofexperimentaldiabeticsanimalmode[j].jclinrehabil(中国临床康复),2005,9:210-212.
|
| [49] | zhanglt,changcq,liuy.effectofchlorogenicacidondisorderedglucoseandlipidmetabolismindb/dbmiceanditsmechanism[j].actaacadmedsin(中国医学科学院学报),2011,33:281-286.
|
| [50] | duh,shaojq,gup,etal.effectofrheintreatmentonfirst-phaseinsulinsecretoryfunctionindb/dbmice[j].chinajchinmatermed(中国中药杂志),2010,35:2764-2767.
|
| [51] | chengl,mengxb,lus,etal.evaluationofhypoglycemicefficacyoftangningtongluoformula,atraditionalchinesemiaomedicine,intworodentanimalmodels[j].jdiabetesres,2014,2014:745419.
|
| [52] | petersonrg,shawwn,neelma,etal.zuckerdiabeticfattyratasamodelfornon-insulin-dependentdiabetesmellitus[j].ilarj,1990,32:16-19.
|
| [53] | nugentda,smithdm,joneshb.areviewofisletoflangerhansdegenerationinrodentmodelsoftype2diabetes[j].toxicolpathol,2008,36:529-551.
|
| [54] | sutoj,matsuuras,imamurak,etal.geneticanalysisofnon-insulin-dependentdiabetesmellitusinkkandkk-aymice[j].eurjendocrinol,1998,139:654-661.
|
| [55] | fujisaway,sakuraih.evidencefortheimprovementofnoninsulin-dependentdiabetesmellitusinkkaymicewithdailyoraladministrationofbis-(6-methylpicolinato)oxovanadium(iv)complex[j].chempharmbull,1999,47:1668-1670.
|
| [56] | kangks,hamj,kimyj,etal.heat-processedpanaxginsenganddiabeticrenaldamage:activecomponentsandactionmechanism[j].jginsengres,2013,37:379-388.
|
| [57] | buqt,zhangwy,chenqc,etal.anti-diabeticeffectofginsenosiderb(3)inalloxan-induceddiabeticmice[j].medchem,2012,8:934-941.
|
| [58] | leehm,leeoh,kimkj,etal.ginsenosiderg1promotesglucoseuptakethroughactivatedampkpathwayininsulin-resistantmusclecells[j].phytotherres,2012,26:1017-1022.
|
| [59] | leekt,jungtw,leehj,etal.theantidiabeticeffectofginsenosiderb2viaactivationofampk[j].archpharmres,2011,34:1201-1208.
|
| [60] | yangcy,wangj,zhaoy,etal.anti-diabeticeffectsofpanaxnotoginsengsaponinsanditsmajoranti-hyperglycemiccomponents[j].jethnopharmacol,2010,20:231-236.
|
| [61] | liz,gengyn,jiangjd,etal.antioxidantandanti-inflammatoryactivitiesofberberineinthetreatmentofdiabetesmellitus[j].evidbasedcomplementalternmed,2014.doi:10.1155/2014/289264.
|
| [62] | zhangxj,dengyx,shiqz,etal.hypolipidemiceffectofthechinesepolyherbalhuanglianjiedudecoctionintype2diabeticratsanditspossiblemechanism[j].phytomedicine,2014,21:615-623.
|
| [63] | renlm,zhuoyj,haozs,etal.berberineimprovesneurogeniccontractileresponseofbladderdetrusormuscleinstreptozotocin-induceddiabeticrats[j].jethnopharmacol,2013,150:1128-1136.
|
| [64] | matveyenkoav,butlerpc.isletamyloidpolypeptide(iapp)transgenicrodentsasmodelsfortype2diabetes[j].ilarj,2006,47:225-233.
|
Full-Text
|
|
Contact Us
service@oalib.com QQ:3279437679 
WhatsApp +8615387084133
|
|
